Stock listing
BMV:VYGR Voyager Therapeutics, Inc. Acciones
Mexican listing (BMV) of Voyager Therapeutics, Inc. · home listing NASDAQ:VYGR
Follow Voyager Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:VYGR
$1.78 USD +0.06 (+3.5%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:VYGR
- Day range
- $1.71 – $1.80 USDNov 2, 2026
- Volume
- 1.19M sharesNov 2, 2026
- Market cap
- $109.7M USDAt the close on Nov 2, 2026 · price × 61.62M shares outstanding
- 52-week range
- $1.68 – $5.48 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.72M USDMedian day 610,400 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VYGR · Home | $1.78 USD | +0.06 (+3.5%) | 1,185,633 | $1.74 | $1.80 | $1.71 | $1.72 | Close on Nov 2, 2026 |
| Frankfurt:VT6 | €1.52 EUR | +0.041 (+2.8%) | — | €1.52 | €1.52 | €1.52 | €1.479 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:VYGR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.78 | +0.06 | +3.5% | $1.74 | $1.80 | $1.71 | 1,185,633 | |
| $1.72 | -0.04 | -2.3% | $1.75 | $1.758 | $1.675 | 873,822 | |
| $1.76 | -0.08 | -4.3% | $1.86 | $1.90 | $1.745 | 659,661 | |
| $1.84 | +0.11 | +6.4% | $1.72 | $1.85 | $1.703 | 1,135,706 | |
| $1.73 | -0.02 | -1.1% | $1.76 | $1.81 | $1.725 | 1,269,396 | |
| $1.75 | +0.01 | +0.6% | $1.78 | $1.78 | $1.71 | 1,661,543 | |
| $1.74 | -0.12 | -6.5% | $1.82 | $1.84 | $1.74 | 1,038,400 | |
| $1.86 | -0.16 | -7.9% | $2.03 | $2.05 | $1.75 | 1,299,700 | |
| $2.02 | -0.17 | -7.8% | $2.02 | $2.16 | $1.97 | 934,800 | |
| $2.19 | +0.14 | +6.8% | $2.05 | $2.29 | $2.02 | 1,126,400 | |
| $2.05 | +0.15 | +7.9% | $1.93 | $2.09 | $1.89 | 1,262,600 | |
| $1.90 | -0.16 | -7.8% | $2.05 | $2.05 | $1.89 | 573,200 | |
| $2.06 | +0.05 | +2.5% | $2.00 | $2.10 | $2.00 | 719,300 | |
| $2.01 | -0.14 | -6.5% | $2.13 | $2.17 | $1.99 | 1,193,500 | |
| $2.15 | -0.12 | -5.3% | $2.24 | $2.26 | $2.14 | 1,060,700 | |
| $2.27 | -0.18 | -7.3% | $2.46 | $2.47 | $2.25 | 967,000 | |
| $2.45 | +0.08 | +3.4% | $2.36 | $2.52 | $2.35 | 694,400 | |
| $2.37 | -0.10 | -4.0% | $2.44 | $2.46 | $2.33 | 932,200 | |
| $2.47 | +0.01 | +0.4% | $2.44 | $2.50 | $2.41 | 763,200 | |
| $2.46 | 0.00 | 0.0% | $2.46 | $2.50 | $2.41 | 617,700 | |
| $2.46 | +0.01 | +0.4% | $2.43 | $2.55 | $2.39 | 1,391,900 | |
| $2.45 | -0.23 | -8.6% | $2.72 | $2.73 | $2.42 | 1,171,700 | |
| $2.68 | 0.00 | 0.0% | $2.67 | $2.75 | $2.63 | 600,100 | |
| $2.68 | +0.04 | +1.5% | $2.66 | $2.72 | $2.61 | 598,500 | |
| $2.64 | -0.06 | -2.2% | $2.70 | $2.70 | $2.58 | 618,600 | |
| $2.70 | +0.02 | +0.7% | $2.68 | $2.73 | $2.61 | 646,100 | |
| $2.68 | -0.12 | -4.3% | $2.78 | $2.79 | $2.64 | 719,900 | |
| $2.80 | -0.07 | -2.4% | $2.87 | $2.88 | $2.71 | 1,094,800 | |
| $2.87 | -0.27 | -8.6% | $3.14 | $3.14 | $2.87 | 690,700 | |
| $3.14 | +0.06 | +1.9% | $3.09 | $3.17 | $3.08 | 341,500 | |
| $3.08 | -0.01 | -0.3% | $3.13 | $3.16 | $3.05 | 292,700 | |
| $3.09 | +0.05 | +1.6% | $3.01 | $3.11 | $3.00 | 538,100 | |
| $3.04 | -0.01 | -0.3% | $3.05 | $3.11 | $3.00 | 681,200 | |
| $3.05 | -0.04 | -1.3% | $3.11 | $3.11 | $2.97 | 632,300 | |
| $3.09 | -0.10 | -3.1% | $3.19 | $3.19 | $3.03 | 452,000 | |
| $3.19 | 0.00 | 0.0% | $3.17 | $3.21 | $3.14 | 305,800 | |
| $3.19 | 0.00 | 0.0% | $3.24 | $3.28 | $3.15 | 276,100 | |
| $3.19 | -0.06 | -1.8% | $3.20 | $3.22 | $3.13 | 334,400 | |
| $3.25 | -0.15 | -4.4% | $3.37 | $3.38 | $3.21 | 500,500 | |
| $3.40 | -0.11 | -3.1% | $3.48 | $3.50 | $3.38 | 488,600 | |
| $3.51 | +0.13 | +3.8% | $3.34 | $3.52 | $3.33 | 406,700 | |
| $3.38 | -0.16 | -4.5% | $3.54 | $3.55 | $3.35 | 619,600 | |
| $3.54 | +0.11 | +3.2% | $3.43 | $3.59 | $3.43 | 434,900 | |
| $3.43 | -0.02 | -0.6% | $3.42 | $3.48 | $3.35 | 461,300 | |
| $3.45 | -0.09 | -2.5% | $3.51 | $3.51 | $3.35 | 395,600 | |
| $3.54 | +0.08 | +2.3% | $3.47 | $3.56 | $3.36 | 406,200 | |
| $3.46 | 0.00 | 0.0% | $3.46 | $3.52 | $3.43 | 262,800 | |
| $3.46 | -0.02 | -0.6% | $3.48 | $3.52 | $3.41 | 279,300 | |
| $3.48 | +0.04 | +1.2% | $3.45 | $3.56 | $3.45 | 306,500 | |
| $3.44 | +0.05 | +1.5% | $3.39 | $3.46 | $3.24 | 406,000 | |
| $3.39 | +0.07 | +2.1% | $3.36 | $3.44 | $3.30 | 424,400 | |
| $3.32 | -0.09 | -2.6% | $3.39 | $3.40 | $3.20 | 717,000 | |
| $3.41 | +0.11 | +3.3% | $3.33 | $3.48 | $3.31 | 638,500 | |
| $3.30 | +0.07 | +2.2% | $3.22 | $3.39 | $3.22 | 658,000 | |
| $3.23 | -0.04 | -1.2% | $3.27 | $3.29 | $3.20 | 238,500 | |
| $3.27 | +0.05 | +1.6% | $3.22 | $3.29 | $3.14 | 306,200 | |
| $3.22 | +0.02 | +0.6% | $3.24 | $3.31 | $3.16 | 545,300 | |
| $3.20 | 0.00 | 0.0% | $3.19 | $3.25 | $3.17 | 376,100 | |
| $3.20 | +0.03 | +0.9% | $3.16 | $3.26 | $3.15 | 398,000 | |
| $3.17 | -0.10 | -3.1% | $3.25 | $3.33 | $3.17 | 393,300 | |
| $3.27 | +0.14 | +4.5% | $3.07 | $3.29 | $3.07 | 469,200 | |
| $3.13 | +0.03 | +1.0% | $3.09 | $3.19 | $3.08 | 421,000 | |
| $3.10 | -0.03 | -1.0% | $3.13 | $3.17 | $3.07 | 582,200 | |
| $3.13 | +0.13 | +4.3% | $3.01 | $3.13 | $2.98 | 429,000 | |
| $3.00 | -0.03 | -1.0% | $3.06 | $3.12 | $2.94 | 610,400 |
- Ticker
- BMV:VYGR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BMV
- Currency
- MXN
What changed lately
Latest news release · Oct 27, 2026
Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
Latest earnings call · Nov 11, 2025
Voyager Therapeutics (NASDAQ:VYGR) Q3 2025 Earnings Call
Replay and transcript
Latest deck · May 15, 2026
ASGCT 2026 Annual Meeting
Conference · 17 slides
Calls
Replays
Voyager Therapeutics (NASDAQ:VYGR) Q3 2025 Earnings Call
Tue, Nov 11, 2025 · 3:20 PM ET
Watch TranscriptVoyager Therapeutics (NASDAQ:VYGR) Q2 2025 Earnings Call
Tue, Aug 12, 2025 · 4:30 PM ET
Watch TranscriptVoyager Therapeutics (NASDAQ:VYGR) Q1 2025 Earnings Call
Tue, May 13, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
Oct 27, 2026
Closed $1.73 (-1.1%) on Oct 27, 2026
Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
Oct 21, 2026
Closed $2.02 (-7.8%) on Oct 21, 2026
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
Jul 13, 2026
Closed $3.24 (-5.8%) on Jul 13, 2026
Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
Jun 29, 2026
Closed $3.58 (-0.3%) on Jun 29, 2026
Voyager to Present at H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference
Jun 11, 2026
Closed $3.46 (+4.2%) on Jun 11, 2026
Voyager Receives FDA IND Clearance for VY1706, First Gene Therapy Approach to Reducing Tau Production in the Brain for Alzheimer’s Disease
Jun 1, 2026
Closed $3.79 (-2.1%) on Jun 1, 2026
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
May 13, 2026
Closed $4.15 (0.0%) on May 13, 2026
Voyager Reports First Quarter 2026 Financial and Operating Results
May 7, 2026
Closed $4.05 (+2.3%) on May 8, 2026
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
Apr 27, 2026
Closed $3.77 (+0.3%) on Apr 28, 2026
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Mar 9, 2026
Closed $4.11 (+5.4%) on Mar 9, 2026
Decks
ASGCT 2026 Annual Meeting
Conference · 17 slides · May 15, 2026
Technical Presentation (May 2026)
Technical · 16 slides · May 2026
Investor Presentation (January 2026)
Investor deck · 29 slides · Jan 8, 2026
CTAD 2025
Conference · 10 slides · December 2025
Voyager Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 104 in all · newest Oct 27, 2026 · oldest 2019
- Calls
- 16 calls with a replay · 16 with a transcript · latest Nov 11, 2025
- Decks
- 9 decks · latest May 15, 2026
Where Voyager Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VYGR · Home listing | NASDAQ | United States | USD |
| Tradegate:VT6 | Tradegate | Germany | EUR |
| BMV:VYGR · This page | BMV | Mexico | MXN |
| gettex:VT6 | gettex | Germany | EUR |
| LS Exchange:A143XJ | LS Exchange | Germany | EUR |
| Lang & Schwarz:A143XJ | Lang & Schwarz | Germany | EUR |
| Frankfurt:VT6 | Frankfurt | Germany | EUR |
| BIVA:VYGR | BIVA | Mexico | MXN |
| BOATS:VYGR | BOATS | United States | USD |
| Dusseldorf:VT6 | Dusseldorf | Germany | EUR |
| Hamburg:VT6 | Hamburg | Germany | EUR |
| Munich:VT6 | Munich | Germany | EUR |
| Stuttgart:VT6 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Voyager Therapeutics, Inc.